SUBSTITUTED IMIDAZOLYLMETHYL PYRIDINE AND PYRAZINE DERIVATIVES: GABAA RECEPTOR LIGANDS

Details for Australian Patent Application No. 2003301864 (hide)

Owner NEUROGEN CORPORATION

Inventors MAYNARD, George; XIE, Linghong; GHOSH, Manuka

Pub. Number AU-A-2003301864

PCT Number PCT/US2003/0143

PCT Pub. Number WO2004/041809

Priority 60/379,117 08.05.02 US

Filing date 7 May 2003

Wipo publication date 7 June 2004

International Classifications

C07D 401/14 Heterocyclic compounds containing two or more hetero rings

A61K 031/4155 - not condensed and containing further heterocyclic rings

A61P 043/00 Drugs for specific purposes, not provided for in groups

C07D 417/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 403/14 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

24 June 2004 Complete Application Filed

  Priority application(s): 60/379,117 08.05.02 US

1 July 2004 Application Open to Public Inspection

  Published as AU-A-2003301864

21 July 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003301865-EPITOPES OF HEPATITIS C VIRUS

2003301863-SULFONYLAMINOVALEROLAC TAMS AND DERIVATIVES THEREOF AS FACTOR Xa INHIBITORS